789 related articles for article (PubMed ID: 12787409)
1. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
Liang K; Vaziri ND
Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
[TBL] [Abstract][Full Text] [Related]
2. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
3. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia.
Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
5. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
8. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
Schuler LA; Toaff ME; Strauss JF
Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
[TBL] [Abstract][Full Text] [Related]
10. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Vaziri ND; Liang K
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1038-43. PubMed ID: 15280162
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.
Vaziri ND; Liang K
Kidney Int; 2002 May; 61(5):1769-75. PubMed ID: 11967026
[TBL] [Abstract][Full Text] [Related]
12. Impact of an enriched-cholesterol diet on enzymatic cholesterol metabolism during rabbit gestation.
Montoudis A; Boileau S; Simoneau L; Lafond J
Life Sci; 2003 Aug; 73(11):1463-77. PubMed ID: 12850506
[TBL] [Abstract][Full Text] [Related]
13. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes.
Merzouk H; Madani S; Boualga A; Prost J; Bouchenak M; Belleville J
J Lipid Res; 2001 Jul; 42(7):1152-9. PubMed ID: 11441144
[TBL] [Abstract][Full Text] [Related]
16. [The enzymes related to lipoprotein metabolism (LpL, H-TGL, LCAT, ACAT, HMG-CoA reductase, 7 alpha-hydroxylase)].
Inadera H; Shirai K; Saito Y
Nihon Rinsho; 1990 Nov; 48(11):2483-91. PubMed ID: 2270012
[No Abstract] [Full Text] [Related]
17. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
Purdy BH; Field FJ
J Clin Invest; 1984 Aug; 74(2):351-7. PubMed ID: 6746898
[TBL] [Abstract][Full Text] [Related]
18. Increasing hepatic cholesterol 7alpha-hydroxylase reduces plasma cholesterol concentrations in normocholesterolemic and hypercholesterolemic rabbits.
Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Tint GS; Parker TS; Roberts J; Batta AK; Chen TS; Zhao Z; Kong X
Hepatology; 1996 Oct; 24(4):882-7. PubMed ID: 8855192
[TBL] [Abstract][Full Text] [Related]
19. Compensatory responses to inhibition of hepatic squalene synthase.
Lopez D; Chambers CM; Keller RK; Ness GC
Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism for the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, of cholesterol 7alpha-hydroxylase and of acyl-coenzyme A:cholesterol acyltransferase by free cholesterol.
Mitropoulos KA; Balasubramaniam S; Venkatesan S; Reeves BE
Biochim Biophys Acta; 1978 Jul; 530(1):99-111. PubMed ID: 687657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]